Agilent/Dako

Postmeiotic Segregation Increased 2 (Autostainer Link 48)

#IR087 · immunohistochemistry

14

Citing papers

241

Combined citations

Supplier page Find this product

Research areas

Genetic factors in colorectal cancer9 Cancer Immunotherapy and Biomarkers3 Colorectal Cancer Treatments and Studies3 Colorectal Cancer Screening and Detection3 Cancer Genomics and Diagnostics3 Cholangiocarcinoma and Gallbladder Cancer Studies2 Colorectal and Anal Carcinomas2 Cancer-related Molecular Pathways1

Papers citing this product

1

Advantage of <i>HSP110</i> (T17) marker inclusion for microsatellite instability (MSI) detection in colorectal cancer patients

Oncotarget·2018·46 cit.·DOI

2

Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma

BMC Medicine·2024·43 cit.·DOI

3

Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression

Modern Pathology·2018·41 cit.·DOI

4

PD‑L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study

Oncology Letters·2021·40 cit.·DOI

5

Clinical Performance of the Idylla MSI Test for a Rapid Assessment of the DNA Microsatellite Status in Human Colorectal Cancer

Journal of Molecular Diagnostics·2019·36 cit.·DOI

6

A Prospective Study on the Roles of the Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), and Platelet-to-Lymphocyte Ratio (PLR) in Patients with Locally Advanced Rectal Cancer

Biomedicines·2023·13 cit.·DOI

7

Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques

Journal of Translational Medicine·2024·6 cit.·DOI

8

Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics

Pathobiology·2022·5 cit.·DOI

9

Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy

Cancer Medicine·2019·4 cit.·DOI

10

Implementation of the ProMisE classifier and validation of its prognostic impact in Brazilian endometrial carcinomas

Frontiers in Oncology·2024·4 cit.·DOI

Also available from other vendors

This target has 15 citing papers across all vendors combined

Vendor	Product	Evidence	Price	Papers
Leica Biosystems	Mismatch Repair Protein (PMS2)	—	—	1

Similar products

Product	Vendor	Evidence	Price	Papers
Mismatch Repair Protein (PMS2)Mouse	Leica Biosystems	—	—	1
Monoclonal Rabbit Anti-Human PMS2, Clone EP51Rabbit	Agilent/Dako	—	—	—

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.